Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

822 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treatment strategy based on gemcitabine-containing salvage chemotherapy used with intent to proceed to second stem cell transplant for patients with Hodgkin lymphoma relapsing after a prior autologous transplant.
Czyz A, Romejko-Jarosinska J, Knopinska-Posluszny W, Nowicki A, Lojko-Dankowska A, Gil L, Dytfeld D, Walewski J, Hellmann A, Komarnicki M. Czyz A, et al. Among authors: gil l. Leuk Lymphoma. 2013 May;54(5):973-8. doi: 10.3109/10428194.2012.734612. Epub 2012 Oct 29. Leuk Lymphoma. 2013. PMID: 23025342
Prognostic factors and long-term outcome of autologous haematopoietic stem cell transplantation following a uniform-modified BEAM-conditioning regimen for patients with refractory or relapsed Hodgkin lymphoma: a single-center experience.
Czyz A, Lojko-Dankowska A, Dytfeld D, Nowicki A, Gil L, Matuszak M, Kozlowska-Skrzypczak M, Kazmierczak M, Bembnista E, Komarnicki M. Czyz A, et al. Among authors: gil l. Med Oncol. 2013;30(3):611. doi: 10.1007/s12032-013-0611-y. Epub 2013 May 24. Med Oncol. 2013. PMID: 23702734 Free PMC article.
Bortezomib has little ex vivo activity in chronic myeloid leukemia: individual tumor response testing comparative study in acute and chronic myeloid leukemia.
Styczyński J, Gil L, Czyżewski K, Kołodziej B, Kuryło-Rafińska B, Lewandowski K, Gniot M, Lewandowska M, Komarnicki M, Wysocki M. Styczyński J, et al. Among authors: gil l. Contemp Oncol (Pozn). 2012;16(3):210-4. doi: 10.5114/wo.2012.29286. Epub 2012 Jul 6. Contemp Oncol (Pozn). 2012. PMID: 23788881 Free PMC article.
The JAK2 V617F mutational status and allele burden may be related with the risk of venous thromboembolic events in patients with Philadelphia-negative myeloproliferative neoplasms.
Borowczyk M, Wojtaszewska M, Lewandowski K, Gil L, Lewandowska M, Lehmann-Kopydłowska A, Kroll-Balcerzak R, Balcerzak A, Iwoła M, Michalak M, Komarnicki M. Borowczyk M, et al. Among authors: gil l. Thromb Res. 2015 Feb;135(2):272-80. doi: 10.1016/j.thromres.2014.11.006. Epub 2014 Nov 15. Thromb Res. 2015. PMID: 25559461
The JAK2 V617F mutational status and allele burden--authors' reply.
Borowczyk M, Wojtaszewska M, Lewandowski K, Gil L, Lewandowska M, Lehmann-Kopydłowska A, Kroll-Balcerzak R, Balcerzak A, Iwoła M, Michalak M, Komarnicki M. Borowczyk M, et al. Among authors: gil l. Thromb Res. 2015 Sep;136(3):691-2. doi: 10.1016/j.thromres.2015.07.006. Epub 2015 Jul 10. Thromb Res. 2015. PMID: 26216656 No abstract available.
Concomitance of monosomal karyotype with at least 5 chromosomal abnormalities is associated with dismal treatment outcome of AML patients with complex karyotype - retrospective analysis of Polish Adult Leukemia Group (PALG).
Wierzbowska A, Wawrzyniak E, Siemieniuk-Rys M, Kotkowska A, Pluta A, Golos A, Robak T, Szarawarska M, Jaskowiec A, Duszenko E, Rybka J, Holojda J, Grosicki S, Pienkowska-Grela B, Woroniecka R, Ejduk A, Watek M, Wach M, Mucha B, Skonieczka K, Czyzewska M, Jachalska A, Klonowska A, Iliszko M, Knopinska-Posluszny W, Jarmuz-Szymczak M, Przybylowicz-Chalecka A, Gil L, Kopacz A, Holowiecki J, Haus O. Wierzbowska A, et al. Among authors: gil l. Leuk Lymphoma. 2017 Apr;58(4):889-897. doi: 10.1080/10428194.2016.1219901. Epub 2016 Aug 26. Leuk Lymphoma. 2017. PMID: 27561449
822 results